About FDA
Cumulative percentage of Center supervisors, managers, and Senior Executive Service (SES) who participated in supervisory, management, or SES training year-to-date (1)
Cumulative FY 2012 Target: 80% of Center supervisors, managers, or SES to participate in training by 9/30/2012
Dictionary: CBER managers are required to assess their supervisory and managerial employees’ individual developmental needs so that those individuals who serve in leadership and management positions are trained to lead and manage their staff more effectively. CBER uses the Department of Health and Human Services Leadership Competencies to develop supervisors and managers as well as the Federal government's Executive Core Qualifications to develop Senior Executive Service (SES) Leaders and Managers. The tracking of training is required by 5 CFR 410, “Training.” Further, skilled managers improve CBER’s ability to address the many challenges presented by the range of products and increase the Center’s effectiveness in protecting public health.
Information is current as of September 30, 2012
Fiscal Year - 2012
Cumulative FY 2012 Target: 80% of Center supervisors, managers, or SES to participate in training by 9/30/2012
| Time | Target | Percent |
|---|---|---|
| October – December 2011 | 80 | 2 |
| January – March 2012 | 80 | 58 |
| April – June 2012 | 80 | 70 |
| July – September 2012 | 80 | 88 |
FY 2012 Cumulative Total: 88%
Footnotes
- (1) Includes government and non-government supervisory, management, leadership, and SES development training.
Cumulative number of Center supervisors, managers, and SES who participated in supervisory, management, or SES training year-to-date (2)
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| October – December 2011 | N/A | 3 |
| January – March 2012 | N/A | 87 |
| April – June 2012 | N/A | 104 |
| July – September 2012 | N/A | 131 |
FY 2012 Cumulative Total: 131
Footnotes
- (2) Due to Center turnover, cumulative total trained may exceed the number of employees or supervisors at month-end.
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.







